Literature DB >> 30870157

Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome?

Jae W Lee1, Michael A Matthay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30870157      PMCID： PMC6799989          DOI： 10.1097/ALN.0000000000002653

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   8.986


× No keyword cloud information.
  17 in total

Review 1.  Acute Respiratory Distress Syndrome.

Authors:  B Taylor Thompson; Rachel C Chambers; Kathleen D Liu
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

2.  Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.

Authors:  Antoine Monsel; Ying-gang Zhu; Stephane Gennai; Qi Hao; Shuling Hu; Jean-Jacques Rouby; Michelle Rosenzwajg; Michael A Matthay; Jae W Lee
Journal:  Am J Respir Crit Care Med       Date:  2015-08-01       Impact factor: 21.405

Review 3.  The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities.

Authors:  Fraser R Millar; Charlotte Summers; Mark J Griffiths; Mark R Toshner; Alastair G Proudfoot
Journal:  Thorax       Date:  2016-03-11       Impact factor: 9.139

4.  Extracellular Vesicles from Interferon-γ-primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli-induced Acute Lung Injury in Rats.

Authors:  Amir K Varkouhi; Mirjana Jerkic; Lindsay Ormesher; Stéphane Gagnon; Sakshi Goyal; Razieh Rabani; Claire Masterson; Chris Spring; Paul Z Chen; Frank X Gu; Claudia C Dos Santos; Gerard F Curley; John G Laffey
Journal:  Anesthesiology       Date:  2019-05       Impact factor: 7.892

5.  Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia.

Authors:  Jeonghyun Park; Seonguk Kim; Hyungsun Lim; Airan Liu; Shuling Hu; JaeHoon Lee; Hanjing Zhuo; Qi Hao; Michael A Matthay; Jae-W Lee
Journal:  Thorax       Date:  2018-08-03       Impact factor: 9.139

6.  Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

Authors:  Michael A Matthay; Carolyn S Calfee; Hanjing Zhuo; B Taylor Thompson; Jennifer G Wilson; Joseph E Levitt; Angela J Rogers; Jeffrey E Gotts; Jeanine P Wiener-Kronish; Ednan K Bajwa; Michael P Donahoe; Bryan J McVerry; Luis A Ortiz; Matthew Exline; John W Christman; Jason Abbott; Kevin L Delucchi; Lizette Caballero; Melanie McMillan; David H McKenna; Kathleen D Liu
Journal:  Lancet Respir Med       Date:  2018-11-16       Impact factor: 30.700

7.  Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.

Authors:  Kyu-Hyun Han; Ae-Kyeong Kim; Min-Hee Kim; Do-Hyung Kim; Ha-Nl Go; Dong-Ik Kim
Journal:  Cell Biol Int       Date:  2015-08-17       Impact factor: 3.612

8.  Six-month quality-of-life and functional status of acute respiratory distress syndrome survivors compared to patients at risk: a population-based study.

Authors:  Michelle Biehl; Rahul Kashyap; Adil H Ahmed; Martin K Reriani; Uchenna R Ofoma; Gregory A Wilson; Guangxi Li; Michael Malinchoc; Jeff A Sloan; Ognjen Gajic
Journal:  Crit Care       Date:  2015-10-02       Impact factor: 9.097

9.  Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators.

Authors:  Konstantin Tsoyi; Sean R R Hall; Jesmond Dalli; Romain A Colas; Sailaja Ghanta; Bonna Ith; Anna Coronata; Laura E Fredenburgh; Rebecca M Baron; Augustine M K Choi; Charles N Serhan; Xiaoli Liu; Mark A Perrella
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

10.  Alveolar macrophage-derived microvesicles mediate acute lung injury.

Authors:  Sanooj Soni; Michael R Wilson; Kieran P O'Dea; Mariko Yoshida; Umar Katbeh; Samantha J Woods; Masao Takata
Journal:  Thorax       Date:  2016-06-10       Impact factor: 9.139
View more
  2 in total

Review 1.  Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges.

Authors:  C H Masterson; A Ceccato; A Artigas; C Dos Santos; P R Rocco; S Rolandsson Enes; D J Weiss; D McAuley; M A Matthay; K English; G F Curley; J G Laffey
Journal:  Intensive Care Med Exp       Date:  2021-12-31

Review 2.  The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing.

Authors:  Hazel Dunbar; Daniel J Weiss; Sara Rolandsson Enes; John G Laffey; Karen English
Journal:  Cells       Date:  2021-11-02       Impact factor: 6.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.